Skip to main content
logo
Neovacs S.A. (EPA:ALNEV)
France flag France · Delayed Price · Currency is EUR
0.7699
+0.0399 (5.47%)
Aug 3, 2026, 5:25 PM CET

Neovacs Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.160.160.290.5300.02
Revenue Growth
22.77%-44.46%-45.39%47868.71%-95.07%-24.32%
Gross Profit
-0.1-0.1-0.030.03-0.58-0.46
Operating Income
-5.35-5.35-6.62-6.91-6.44-7.83
Net Income
-4.9-4.9-32.91-8.74-3.55-11.84
Earnings Per Share
------
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.570.570.440.896.7633.09
Total Debt
0.540.540.230.651.21.03
Net Cash (Debt)
0.030.030.210.245.5532.06
Net Cash Growth
--83.31%-13.29%-95.74%-82.67%231.12%
Net Cash Per Share
---0.6782.27474.76

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5.03-5.03-3.6-1.91-4.45-9.91
Capital Expenditures
-0.01-0.01-0.08-0.2-0.15-0.35
Free Cash Flow
-5.04-5.04-3.68-2.12-4.6-10.26
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-61.86%-61.86%-11.20%5.50%-51825.30%-2051.10%
Operating Margin
-3306.87%-3306.87%-2273.11%-1294.97%-579583.00%-34725.60%
Pretax Margin
-3415.45%-3415.45%-11653.84%-1803.52%-390822.03%-55356.01%
Profit Margin
-3026.84%-3026.84%-11298.90%-1639.16%-319110.00%-52512.20%
FCF Margin
-3115.05%-3115.05%-1263.59%-396.80%-413782.00%-45498.70%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
--0000
PS Ratio
0.582.010.600.00--